Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Low Dose Intravenous Heparin in Preventing Thromboembolism in the SICU.

NCT01608906 is registered in ClinicalTrials.gov with University of Colorado, Denver as lead sponsor.

NCT NCT01608906
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01608906 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Low Dose Intravenous Heparin in Preventing Thromboembolism in the SICU.
Lead sponsor
University of Colorado, Denver
Phase
Not applicable
Overall status
Completed
Start date
May 31, 2007
Completion date
May 31, 2014
Enrollment
152 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

venous thrombosis